Background and aims: It is known that the majority of critical unacknowledged hypoglycemia has an increased incidence in patients with type 1 diabetes (T1DM) with a long evolution. The aim of this research is to evaluate the variability of glucose level and hypoglycemic events in patients with type 2 diabetes (T2DM) having pharmacological interventions with hypoglycemic risk. These events are sometimes asymptomatic also in T2DM: frequently in elderly, patients with autonomic neuropathy, or having a long evolution of disease
Context: Hypoglycemia is a well-recognized adverse effect in the treatment of type 1 diabetes mellit...
AIM: In type 1 diabetic patients (T1DM), nocturnal hypoglycaemias (NH) are a serious complication of...
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2...
Based on the baseline data of a multi-center randomized CGM trial (HypoDE), we analyzed the glucose ...
Introduction Observational studies constitute an important evidence base for hypoglycemia in diabete...
BACKGROUND: Hypoglycemia is often the limiting factor for intensive glucose control in diabetes mana...
OBJECTIVEdSleep-disordered breathing and sleepiness cause metabolic, cognitive, and be-havioral dist...
Background: The present study was designed to define the relative contributions of glucose variabili...
The review of literature considers questions of hypoglycemia as a limiting factor in the treatment o...
Given that iatrogenic hypoglycemia often occurs during the night in people with type 1 diabetes, we ...
Hypoglycemia is one of the most important complications of diabetes treatment and it becomes an obst...
T he importance of strict glycemiccontrol to limit the risk of diabeticvascular complications is ind...
Abstract Aim Analysed clinical characteristics and influencing factors for hypoglycemia in hospitali...
AIMS: Hypoglycemia is a limiting factor for achieving stringent glycemic control in diabetes. This s...
For patients with diabetes, hypoglycaemia can present a number of risks ranging from mild to life-th...
Context: Hypoglycemia is a well-recognized adverse effect in the treatment of type 1 diabetes mellit...
AIM: In type 1 diabetic patients (T1DM), nocturnal hypoglycaemias (NH) are a serious complication of...
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2...
Based on the baseline data of a multi-center randomized CGM trial (HypoDE), we analyzed the glucose ...
Introduction Observational studies constitute an important evidence base for hypoglycemia in diabete...
BACKGROUND: Hypoglycemia is often the limiting factor for intensive glucose control in diabetes mana...
OBJECTIVEdSleep-disordered breathing and sleepiness cause metabolic, cognitive, and be-havioral dist...
Background: The present study was designed to define the relative contributions of glucose variabili...
The review of literature considers questions of hypoglycemia as a limiting factor in the treatment o...
Given that iatrogenic hypoglycemia often occurs during the night in people with type 1 diabetes, we ...
Hypoglycemia is one of the most important complications of diabetes treatment and it becomes an obst...
T he importance of strict glycemiccontrol to limit the risk of diabeticvascular complications is ind...
Abstract Aim Analysed clinical characteristics and influencing factors for hypoglycemia in hospitali...
AIMS: Hypoglycemia is a limiting factor for achieving stringent glycemic control in diabetes. This s...
For patients with diabetes, hypoglycaemia can present a number of risks ranging from mild to life-th...
Context: Hypoglycemia is a well-recognized adverse effect in the treatment of type 1 diabetes mellit...
AIM: In type 1 diabetic patients (T1DM), nocturnal hypoglycaemias (NH) are a serious complication of...
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2...